ExperimentSetReplicate

ExperimentSet4DNESHYMOHEK
released
View JSON

Replicates of in situ Hi-C on control Crispr treated but unmodified WTC-11 iPSC cells differentiated for 23 days to cardiac myocytes.

   August 18th, 2022 at 9:14pm
Source Publication
Dose-dependent sensitivity of human 3D chromatin to a heart disease-linked transcription factor
Grant ZL, Kuang S, et al., bioRxiv 2025

Assay Description  

Experiment Set Properties  

Set Type 
Replicate
Organism 
H. sapiens
Sample Type 
in vitro differentiated cells
Sample 
WTC-11 differentiated to cardiac muscle cell
Experiment Type(s) 
in situ Hi-C
Modification Type 
None
Treatment Type 
None
Assay Details 
Enzyme: Arima - A1, A2

10 Processed Files

Quality Metrics

Experiment
For File
Filtered Reads
Cis reads (>20kb)
Short cis reads
Trans Reads
Details
From Multiple Experiments
4DNESHYMOHEK
Multiple Experiments
File
Contact List-combined (pairs)
4DNFISPTK5RW
1.36 billion
46.952%
31.377%
21.671%
Experiment
4DNEXM86GNJY
Bio Rep 1, Tec Rep 1
in situ Hi-C on WTC-11 differentiated to cardiac muscle cell with Arima - A1, A2
File
Contact List-replicate (pairs)
4DNFI1KNE8W8
726.26m
47.52%
31.312%
21.168%
Experiment
4DNEXF74JWUP
Bio Rep 2, Tec Rep 1
in situ Hi-C on WTC-11 differentiated to cardiac muscle cell with Arima - A1, A2
File
Contact List-replicate (pairs)
4DNFILRJH4D4
631.08m
46.298%
31.451%
22.251%
Experiment
For File
Failed Balancing
Details
From Multiple Experiments
4DNESHYMOHEK
Multiple Experiments
File
Contact Matrix (mcool)
4DNFI5MNOB1Y
None
Experiment
For File
Total Reads
Unmapped Reads
Multimapped Reads
Duplicate Reads
Walks
Minor Contigs
Details
Experiment
4DNEXM86GNJY
Bio Rep 1, Tec Rep 1
in situ Hi-C on WTC-11 differentiated to cardiac muscle cell with Arima - A1, A2
File
Alignments (bam)
4DNFISD2ZXV5
1.36 billion
4.579%
7.296%
23.214%
11.438%
0.239%
Experiment
4DNEXF74JWUP
Bio Rep 2, Tec Rep 1
in situ Hi-C on WTC-11 differentiated to cardiac muscle cell with Arima - A1, A2
File
Alignments (bam)
4DNFIUTXMFXY
1.19 billion
4.516%
7.51%
23.334%
11.518%
0.253%